263 related articles for article (PubMed ID: 9819300)
1. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases.
Hingorani M; Calder V; Jolly G; Buckley RJ; Lightman SL
J Allergy Clin Immunol; 1998 Nov; 102(5):821-30. PubMed ID: 9819300
[TBL] [Abstract][Full Text] [Related]
2. The role of conjunctival epithelial cells in chronic ocular allergic disease.
Hingorani M; Calder VL; Buckley RJ; Lightman SL
Exp Eye Res; 1998 Nov; 67(5):491-500. PubMed ID: 9878210
[TBL] [Abstract][Full Text] [Related]
3. T-cell cytokines in chronic allergic eye disease.
Metz DP; Hingorani M; Calder VL; Buckley RJ; Lightman SL
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):817-24. PubMed ID: 9438492
[TBL] [Abstract][Full Text] [Related]
4. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
Leonardi A; Jose PJ; Zhan H; Calder VL
Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
[TBL] [Abstract][Full Text] [Related]
5. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis.
Uchio E; Ono SY; Ikezawa Z; Ohno S
Clin Exp Allergy; 2000 Jan; 30(1):103-9. PubMed ID: 10606937
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
Hingorani M; Calder VL; Buckley RJ; Lightman S
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil cationic protein in tears in allergic conjunctivitis.
Montan PG; van Hage-Hamsten M
Br J Ophthalmol; 1996 Jun; 80(6):556-60. PubMed ID: 8759270
[TBL] [Abstract][Full Text] [Related]
8. The implications of the upregulation of ICAM-1/VCAM-1 expression of corneal fibroblasts on the pathogenesis of allergic keratopathy.
Okada N; Fukagawa K; Takano Y; Dogru M; Tsubota K; Fujishima H; Matsumoto K; Nakajima T; Saito H
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4512-8. PubMed ID: 16303942
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease.
Calder VL; Jolly G; Hingorani M; Adamson P; Leonardi A; Secchi AG; Buckley RJ; Lightman S
Clin Exp Allergy; 1999 Sep; 29(9):1214-22. PubMed ID: 10469030
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 concentrations in conjunctival epithelium brush cytology samples correlate with neutrophil, eosinophil infiltration, and corneal damage.
Miyoshi T; Fukagawa K; Shimmura S; Fujishima H; Takano Y; Takamura E; Tsubota K; Saito H; Oguchi Y
Cornea; 2001 Oct; 20(7):743-7. PubMed ID: 11588428
[TBL] [Abstract][Full Text] [Related]
11. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.
Hu Y; Matsumoto Y; Dogru M; Okada N; Igarashi A; Fukagawa K; Tsubota K; Fujishima H
Allergy; 2007 Aug; 62(8):917-25. PubMed ID: 17620070
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil and eosinophil participation in atopic and vernal keratoconjunctivitis.
Trocme SD; Leiferman KM; George T; Bonini S; Foster CS; Smit EE; Sra SK; Grabowski LR; Dohlman CH
Curr Eye Res; 2003 Jun; 26(6):319-25. PubMed ID: 12868012
[TBL] [Abstract][Full Text] [Related]
13. Th1- and Th2-type cytokines in chronic ocular allergy.
Leonardi A; Fregona IA; Plebani M; Secchi AG; Calder VL
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1240-5. PubMed ID: 16538446
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.
Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
Mol Vis; 2011; 17():3208-23. PubMed ID: 22194647
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases.
Fujishima H; Okada N; Matsumoto K; Fukagawa K; Igarashi A; Matsuda A; Ono J; Ohta S; Mukai H; Yoshikawa M; Izuhara K
J Allergy Clin Immunol; 2016 Aug; 138(2):459-467.e2. PubMed ID: 26964692
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis.
Fernandez A; Asbell P; Roy N
Ocul Surf; 2022 Oct; 26():191-196. PubMed ID: 35970432
[TBL] [Abstract][Full Text] [Related]
17. Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis.
Shoji J; Inada N; Sawa M
Jpn J Ophthalmol; 2006; 50(3):195-204. PubMed ID: 16767372
[TBL] [Abstract][Full Text] [Related]
18. [Role of corneal fibroblasts in the pathogenesis of ocular allergic diseases].
Fukuda K
Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):717-26. PubMed ID: 16363665
[TBL] [Abstract][Full Text] [Related]
19. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
Vichyanond P; Pacharn P; Pleyer U; Leonardi A
Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
[TBL] [Abstract][Full Text] [Related]
20. Allergic eye disease--a clinical challenge.
Buckley RJ
Clin Exp Allergy; 1998 Dec; 28 Suppl 6():39-43. PubMed ID: 9988434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
